Pharmaceuticals

Drug Development Drug Pricing Drug Approval Drug Safety Weight Loss Drugs Clinical Trials Prescription Drugs Biotechnology Drug Manufacturing Drug Regulation

Lilly Launches $4.5 Billion Indiana Buildout With Opening of First Genetic-Medicine Plant

A planned API complex by 2027 will make medicines for obesity and diabetes to bolster U.S. supply.

Novo Nordisk Lifts Outlook After Wegovy Pill Powers Big Q1 Beat

White House Puts $529 Billion Price Tag on Savings From Trump Drug Deals

Supreme Court Pauses 5th Circuit Block on Mailed Abortion Pill Access

Gossamer Bio Faces Securities Class Action After PROSERA Failure, 80% Stock Plunge

Stories older than 24h

Krystal Biotech Reports Strong Q1 on VYJUVEK, Readies Wider Launches

ADC Therapeutics Reports Higher Q1 Sales and Lower Costs as Zenlonta Readouts Near

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Pfizer Tops Q1 Forecasts on Eliquis Strength, Reaffirms 2026 Outlook

Supreme Court Temporarily Restores Mail and Telehealth Access to Abortion Pill

Amgen Invests $300 Million to Expand Puerto Rico Biologics Plant

Baron Health Care Fund Falls 6.97% in Q1, Repositions for Long-Term Growth

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Supreme Court Skeptical of Expanding Inducement Liability in Skinny-Label Drug Case

Doctors Outline Safe Use of Peptides as FDA Weighs Easing Restrictions

Cigna to Exit ACA Individual Market at Year-End, Affecting 369,000 Members

Pfizer Settles With Three Generics to Keep Vyndamax Exclusive Until 2031

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

Cardinal Health Lifts 2026 Profit Outlook After Q3 Beat Despite Sales Miss

Regeneron Tops Q1 Estimates as Dupixent and Libtayo Outpace Eylea